← Eichor
Condition: Moderate To Severe Acute Respiratory Distress Syndrome Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Moderate To Severe Acute Respiratory Distress Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Phase 3 · 32 location(s) · Direct Biologics, LLC · NCT05354141
Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06430554
Effects on Biotrauma of NMBAs and PP Association During ARDS
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT06212492
Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma
Phase 3 · 1 location(s) · University Hospital, Strasbourg, France · NCT03368092
The Impact of PEEP-guided Electrical Impedance Tomography on Oxygenation and Pulmonary Mechanics in Moderate-to-severe A
NA · 1 location(s) · Vietnam Military Medical University · NCT06733168
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
Phase 2 · 70 location(s) · BioAegis Therapeutics Inc. · NCT05947955
Practices of Prone Positioning Ventilation in Patients With Moderate-to-Severe ARDS in Intensive Care Units: A Registry-
Phase N/A · 1 location(s) · Southeast University, China · NCT07284888
Full-Course ECMO Strategy for Moderate-to-Severe ARDS
NA · 39 location(s) · Southeast University, China · NCT07726953
Enteral Nutrition Delivery in Prone Position Ventilated Patients With Moderate to Severe ARDS
NA · 1 location(s) · Southeast University, China · NCT07362537
Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS
Phase N/A · 39 location(s) · Southeast University, China · NCT07726940
A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory D
Phase 1/Phase 2 · 1 location(s) · Changchun Tuohua Pharmaceutical Co., Ltd. · NCT07413978
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.